TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mcpherson’S Limited ( (AU:MCP) ) just unveiled an update.
McPherson’s Limited has secured a new three-year debt facility with HSBC for $16.2 million, comprising a $10 million receivables finance facility and a $6.2 million revolving credit facility. This move follows a strategic transformation that reduced the company’s financing needs, aligning with its new operating model and net cash position, and marks a significant step in refinancing efforts ahead of the March 2026 expiration of its previous $52.5 million facility.
The most recent analyst rating on (AU:MCP) stock is a Hold with a A$0.22 price target. To see the full list of analyst forecasts on Mcpherson’S Limited stock, see the AU:MCP Stock Forecast page.
More about Mcpherson’S Limited
McPherson’s Limited is a supplier of essential health, beauty, and wellness products in Australia, featuring iconic brands such as ‘Manicare’, ‘Lady Jayne’, ‘Dr. LeWinn’s’, ‘Swisspers’, and ‘Fusion Health’. The company focuses on expanding these brands through pharmacy, grocery, and e-commerce channels, while also offering a portfolio of popular brands in segments like footwear, haircare, vitamins, supplements, fragrance, and nutrition. Headquartered in Sydney, McPherson’s is listed on the Australian Securities Exchange.
Average Trading Volume: 331,767
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$31.67M
For a thorough assessment of MCP stock, go to TipRanks’ Stock Analysis page.